Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Tag:
Syngene Expansion
Syngene International Inaugurates Advanced Clinical Translational Sciences Laboratory in Bengaluru
Breaking News
Dose Daily News Bureau
-
July 17, 2026
Syngene International Limited has inaugurated its state-of-the-art Clinical Translational Sciences Laboratory in Bengaluru. The milestone event was celebrated by Executive Chairperson Dr. Kiran Mazumdar Shaw,...
I want in
I've read and accept the
Privacy Policy
.
MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities
Dose Daily News Bureau
-
September 11, 2026
Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation
Breaking News
ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore
Breaking News
India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration
Breaking News
Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia
Breaking News
Biocon Inks 10-Year Strategic Supply Contract for Breast Cancer Therapy Pertuzumab in Brazil
Breaking News
modal-check
🏆
Dismiss ad
Dismiss ad
This will close in
20
seconds
×